Treating Diabetes by Altering Other Cells to Produce Insulin
Lifespan.io (LEAF) - 04-Jul-2017Novel approach seeks to cure type 1 diabetes and to allow type 2 diabetics to stop using insulin ...
Join the club for FREE to access the whole archive and other member benefits.
Professor and Division Chief at UT Health San Antonio
Dr. Ralph DeFronzo graduated from Yale University with a degree in biology and biochemistry before going on to Harvard Medical School. Following internal medicine training at Johns Hopkins, he completed fellowships in Endocrinology (NIH, Baltimore City Hospital) and Nephrology (Hospital of the University of Pennsylvania). He holds the Joe R. & Teresa Lozano Long Distinguished Chair in Diabetes in the Long School of Medicine at UT Health San Antonio, where he has been on the faculty since 1988. Dr. DeFronzo is directly responsible for many seminal advances achieved in diabetes over the last 50 years. He was a leader in developing the concept of insulin resistance, the defining characteristic of Type 2 diabetes, resulting in novel ideas about the development and progression of diabetes.
Visit website: https://www.uthscsa.edu/patient-care/physicians/providers/1851408843/Ralph-DeFronzo
See also: UT Health San Antonio - Public academic health science center in San Antonio, Texas.
Details last updated 05-Aug-2020
11-Oct-2021 to 14-Oct-2021
The Kitalys institute virtual conference targeting key questions that will impact the future of aging and extending healthspan
Novel approach seeks to cure type 1 diabetes and to allow type 2 diabetics to stop using insulin ...